GOODRX HOLDINGS INC-CLASS A (GDRX) Stock Fundamental Analysis
NASDAQ:GDRX - Nasdaq - US38246G1085 - Common Stock - Currency: USD
Taking everything into account, GDRX scores 6 out of 10 in our fundamental rating. GDRX was compared to 36 industry peers in the Health Care Technology industry. GDRX has an average financial health and profitability rating. GDRX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make GDRX a good candidate for value investing.
1. Profitability
1.1 Basic Checks
GDRX had positive earnings in the past year.
GDRX had a positive operating cash flow in the past year.
GDRX had negative earnings in 4 of the past 5 years.
GDRX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.19%, GDRX belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
The Return On Equity of GDRX (4.34%) is better than 91.67% of its industry peers.
GDRX's Return On Invested Capital of 5.42% is amongst the best of the industry. GDRX outperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.19% | ||
| ROE | 4.34% | ||
| ROIC | 5.42% |
ROA(3y)-0.48%
ROA(5y)-4.6%
ROE(3y)-0.99%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of GDRX (3.56%) is better than 88.89% of its industry peers.
In the last couple of years the Profit Margin of GDRX has declined.
GDRX has a better Operating Margin (10.25%) than 91.67% of its industry peers.
GDRX's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 93.84%, GDRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of GDRX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.25% | ||
| PM (TTM) | 3.56% | ||
| GM | 93.84% |
OM growth 3Y66.5%
OM growth 5Y-25.43%
PM growth 3YN/A
PM growth 5Y-34.7%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
GDRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GDRX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for GDRX remains at a similar level compared to 5 years ago.
Compared to 1 year ago, GDRX has an improved debt to assets ratio.
2.2 Solvency
GDRX has an Altman-Z score of 1.33. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
GDRX has a Altman-Z score (1.33) which is in line with its industry peers.
The Debt to FCF ratio of GDRX is 6.18, which is on the high side as it means it would take GDRX, 6.18 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 6.18, GDRX is doing good in the industry, outperforming 61.11% of the companies in the same industry.
GDRX has a Debt/Equity ratio of 0.74. This is a neutral value indicating GDRX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.74, GDRX is doing worse than 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 6.18 | ||
| Altman-Z | 1.33 |
ROIC/WACC0.51
WACC10.61%
2.3 Liquidity
A Current Ratio of 5.24 indicates that GDRX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.24, GDRX belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
A Quick Ratio of 5.24 indicates that GDRX has no problem at all paying its short term obligations.
GDRX's Quick ratio of 5.24 is amongst the best of the industry. GDRX outperforms 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.24 | ||
| Quick Ratio | 5.24 |
3. Growth
3.1 Past
GDRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.24%, which is quite good.
GDRX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -25.13% yearly.
The Revenue has been growing slightly by 4.34% in the past year.
Measured over the past years, GDRX shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y (TTM)17.24%
EPS 3Y0%
EPS 5Y-25.13%
EPS Q2Q%12.5%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%2.57%
3.2 Future
Based on estimates for the next years, GDRX will show a very strong growth in Earnings Per Share. The EPS will grow by 20.44% on average per year.
Based on estimates for the next years, GDRX will show a small growth in Revenue. The Revenue will grow by 5.92% on average per year.
EPS Next Y19.87%
EPS Next 2Y19.07%
EPS Next 3Y16.92%
EPS Next 5Y20.44%
Revenue Next Year3.3%
Revenue Next 2Y4.32%
Revenue Next 3Y5.19%
Revenue Next 5Y5.92%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
GDRX is valuated correctly with a Price/Earnings ratio of 14.72.
Based on the Price/Earnings ratio, GDRX is valued cheaper than 97.22% of the companies in the same industry.
When comparing the Price/Earnings ratio of GDRX to the average of the S&P500 Index (26.86), we can say GDRX is valued slightly cheaper.
With a Price/Forward Earnings ratio of 10.70, the valuation of GDRX can be described as very reasonable.
Based on the Price/Forward Earnings ratio, GDRX is valued cheaply inside the industry as 97.22% of the companies are valued more expensively.
GDRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.43, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.72 | ||
| Fwd PE | 10.7 |
4.2 Price Multiples
GDRX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GDRX is cheaper than 83.33% of the companies in the same industry.
GDRX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GDRX is cheaper than 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.51 | ||
| EV/EBITDA | 12.45 |
4.3 Compensation for Growth
GDRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GDRX has a very decent profitability rating, which may justify a higher PE ratio.
GDRX's earnings are expected to grow with 16.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.74
PEG (5Y)N/A
EPS Next 2Y19.07%
EPS Next 3Y16.92%
5. Dividend
5.1 Amount
GDRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:GDRX (6/27/2025, 9:38:09 AM)
5.005
+0.08 (+1.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners59.39%
Inst Owner Change-10.38%
Ins Owners11.68%
Ins Owner Change5.85%
Market Cap1.79B
Analysts75.65
Price Target6.44 (28.67%)
Short Float %5.07%
Short Ratio3.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.88%
Min EPS beat(2)-8.64%
Max EPS beat(2)-7.12%
EPS beat(4)0
Avg EPS beat(4)-8.74%
Min EPS beat(4)-10.15%
Max EPS beat(4)-7.12%
EPS beat(8)4
Avg EPS beat(8)0.12%
EPS beat(12)8
Avg EPS beat(12)16.11%
EPS beat(16)10
Avg EPS beat(16)12.75%
Revenue beat(2)0
Avg Revenue beat(2)-2.08%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-1.6%
Revenue beat(4)0
Avg Revenue beat(4)-2.05%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-1.6%
Revenue beat(8)0
Avg Revenue beat(8)-2.2%
Revenue beat(12)2
Avg Revenue beat(12)-1.38%
Revenue beat(16)2
Avg Revenue beat(16)-1.48%
PT rev (1m)-3.75%
PT rev (3m)-4.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.15%
EPS NY rev (3m)-2.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.37%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.72 | ||
| Fwd PE | 10.7 | ||
| P/S | 2.24 | ||
| P/FCF | 22.51 | ||
| P/OCF | 11.89 | ||
| P/B | 2.73 | ||
| P/tB | 54.17 | ||
| EV/EBITDA | 12.45 |
EPS(TTM)0.34
EY6.79%
EPS(NY)0.47
Fwd EY9.35%
FCF(TTM)0.22
FCFY4.44%
OCF(TTM)0.42
OCFY8.41%
SpS2.23
BVpS1.83
TBVpS0.09
PEG (NY)0.74
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.19% | ||
| ROE | 4.34% | ||
| ROCE | 6.86% | ||
| ROIC | 5.42% | ||
| ROICexc | 7.25% | ||
| ROICexgc | 23.91% | ||
| OM | 10.25% | ||
| PM (TTM) | 3.56% | ||
| GM | 93.84% | ||
| FCFM | 9.96% |
ROA(3y)-0.48%
ROA(5y)-4.6%
ROE(3y)-0.99%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.98%
ROICexcg growth 5Y-33.13%
ROICexc growth 3Y52.13%
ROICexc growth 5Y-28.35%
OM growth 3Y66.5%
OM growth 5Y-25.43%
PM growth 3YN/A
PM growth 5Y-34.7%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score8
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 6.18 | ||
| Debt/EBITDA | 3.1 | ||
| Cap/Depr | 94.67% | ||
| Cap/Sales | 8.9% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 95.96% | ||
| Profit Quality | 279.61% | ||
| Current Ratio | 5.24 | ||
| Quick Ratio | 5.24 | ||
| Altman-Z | 1.33 |
F-Score8
WACC10.61%
ROIC/WACC0.51
Cap/Depr(3y)84.57%
Cap/Depr(5y)109.65%
Cap/Sales(3y)7.83%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.24%
EPS 3Y0%
EPS 5Y-25.13%
EPS Q2Q%12.5%
EPS Next Y19.87%
EPS Next 2Y19.07%
EPS Next 3Y16.92%
EPS Next 5Y20.44%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%2.57%
Revenue Next Year3.3%
Revenue Next 2Y4.32%
Revenue Next 3Y5.19%
Revenue Next 5Y5.92%
EBIT growth 1Y367.7%
EBIT growth 3Y69.92%
EBIT growth 5Y-13.99%
EBIT Next Year38.86%
EBIT Next 3Y17.8%
EBIT Next 5Y14.15%
FCF growth 1Y-13.59%
FCF growth 3Y-7.56%
FCF growth 5Y8%
OCF growth 1Y0.95%
OCF growth 3Y0.96%
OCF growth 5Y17.17%